SecBot SecBot
8-K ·Filed Sep 24, 2026

CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE
NEUTRAL
Impact 2/10
Horizonmonths Processed1mo ago SEC0001801170-26-000229
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

Routine board expansion with no immediate financial or strategic catalyst. Monitor for any future strategic shifts or policy commentary from the new directors, but no near-term trading signal.

DirectionNeutral
Confidencehigh
Horizonmonths
Latest settled — T+20d
CLOV ▲ +2.45% at T+20d
NEUTRAL call +2.45% · α vs SPY +3.93% · entry $4.49 → $4.60
Next anchor: T+60d in 7w
Entry = T+0 close
Sep 24, 2026
via day close
T+1d
-3.56%
call -3.56% · α -2.82%
$4.33
settled 5w ago
T+5d
-2.45%
call -2.45% · α -2.23%
$4.38
settled 26d ago
T+20d
+2.45%
call +2.45% · α +3.93%
$4.60
settled 5d ago
T+60d
Pending
in 7w

Price Chart

Loading chart...

Executive Summary

Clover Health appointed former U.S. Senator Robert Torricelli and Dr. Brian J. Miller to its Board of Directors, filling two previously disclosed vacancies and expanding the board to nine members. Torricelli brings policy and insurance subsidiary experience, while Miller adds clinical and Medicare policy expertise. This is a routine board expansion with no financial impact or change in control.

Key Facts

  • Appointed former U.S. Senator Robert Torricelli as Class I director and Dr. Brian J. Miller as Class III director, effective September 22, 2026.
  • Torricelli will serve on the Audit Committee; Miller will serve on the Clinical Committee.
  • Appointments fill two previously disclosed vacancies and bring the board to nine directors.
  • Each new director will receive a pro-rated portion of the annual retainer and a pro-rated RSU award with a value of $200,000, prorated from appointment date to December 31, 2026.
  • Torricelli has served on the board of Clover's insurance subsidiaries since 2022.

Financial Impact

Pro-rated RSU awards of $200,000 each, prorated for the remainder of 2026 — immaterial relative to company size.

Investment Themes

Traditional Finance

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001801170-26-000229
Document: aex991xpressreleasedated92.htm0001801170-26-000229
Document: 0001801170-26-000229-index-headers.html0001801170-26-000229
Document: 0001801170-26-000229-index.html0001801170-26-000229
Document: 0001801170-26-000229.txt0001801170-26-000229
29 reports for CLOV
Performance horizon
67% Hit rate @ T+1 6 of 9 directional calls Went positive at some point 7 of 9 best @ T+5▲ +4.63%Sep 18, 2026
Filters
Rows
Reports for CLOV — sortable, filterable
TypeNow
Oct 20, 2026
7d ago
Insider Cluster
BEARISH ★ 4/10
$4.78 $4.73▲ +1.05%▼ −0.13%$4.63 (+3.14%)
Oct 19, 2026
8d ago
144
NEUTRAL ★ 2/10
$4.80 $4.78▼ −0.42%▼ −0.94%$4.63 (−3.54%)
Oct 19, 2026
8d ago
Insider Cluster
NEUTRAL ★ 2/10
$4.80 $4.78▼ −0.42%▼ −0.94%$4.63 (−3.54%)
Oct 8, 2026
18d ago
8-K
BULLISH ★ 6/10
$4.79 $4.78▼ −0.21%▼ −0.15%$4.63 (−3.34%)
Oct 7, 2026
20d ago
144
NEUTRAL ★ 2/10
$4.58 $4.79▲ +4.59%▲ +3.99%$4.63 (+1.09%)
Oct 5, 2026
21d ago
Insider Cluster
BEARISH ★ 5/10
$4.60 $4.56▲ +0.87%▲ +0.63%$4.63 (−0.65%)
Oct 1, 2026
25d ago
3
NEUTRAL ★ 2/10
$4.38 $4.68▲ +6.85%▲ +6.17%$4.63 (+5.71%)
Sep 24, 2026
4w ago
8-K
NEUTRAL ★ 2/10
$4.49 $4.33▼ −3.56%▼ −2.82%$4.63 (+3.12%)
Sep 18, 2026
5w ago
Insider Cluster
BEARISH ★ 5/10
$4.54 $4.67▼ −2.86%▼ −2.88%$4.63 (−1.98%)
Sep 17, 2026
5w ago
Insider Cluster
BEARISH ★ 5/10
$4.46 $4.54▼ −1.79%▼ −0.24%$4.63 (−3.81%)
Showing 10 of 29

US Market Status

Market Closed — Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 24, 2026